technetium tc 99m hydroxymethylene diphosphonate has been researched along with Osteoradionecrosis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Hayama, K; Kameta, A; Oda, T; Ogura, I; Sasaki, Y; Sue, M | 1 |
Bachmann, G; Bauer, R; Klett, R; Rau, WS; Rössler, R | 1 |
2 other study(ies) available for technetium tc 99m hydroxymethylene diphosphonate and Osteoradionecrosis
Article | Year |
---|---|
Tc-99m hydroxymethylene diphosphonate SPECT/CT for the evaluation of osteonecrosis of the jaw: preliminary study on diagnostic ability of maximum standardised uptake value.
Topics: Aged; Aged, 80 and over; Arthritis, Rheumatoid; Bisphosphonate-Associated Osteonecrosis of the Jaw; Female; Humans; Male; Mandibular Diseases; Middle Aged; Osteoradionecrosis; Radiopharmaceuticals; Single Photon Emission Computed Tomography Computed Tomography; Technetium Tc 99m Medronate; Whole Body Imaging | 2020 |
The role of magnetic resonance imaging and scintigraphy in the diagnosis of pathologic changes of the mandible after radiation therapy.
Topics: Adult; Aged; False Positive Reactions; Female; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Mandible; Mandibular Diseases; Mandibular Neoplasms; Middle Aged; Mouth Neoplasms; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Osteomyelitis; Osteoradionecrosis; Periodontitis; Prospective Studies; Radiation Injuries; Radiation Monitoring; Radiopharmaceuticals; Radiotherapy; Radiotherapy Dosage; Sensitivity and Specificity; Technetium Tc 99m Medronate; Tomography, Emission-Computed, Single-Photon | 1996 |